Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18,485 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TERT promoter mutation subtypes and survival in stage I and II melanoma patients.
Andrés-Lencina JJ, Rachakonda S, García-Casado Z, Srinivas N, Skorokhod A, Requena C, Soriano V, Kumar R, Nagore E. Andrés-Lencina JJ, et al. Among authors: kumar r. Int J Cancer. 2019 Mar 1;144(5):1027-1036. doi: 10.1002/ijc.31780. Epub 2018 Oct 4. Int J Cancer. 2019. PMID: 30070694 Free article.
Telomere length, telomerase reverse transcriptase promoter mutations, and melanoma risk.
Rachakonda S, Kong H, Srinivas N, Garcia-Casado Z, Requena C, Fallah M, Heidenreich B, Planelles D, Traves V, Schadendorf D, Nagore E, Kumar R. Rachakonda S, et al. Among authors: kumar r. Genes Chromosomes Cancer. 2018 Nov;57(11):564-572. doi: 10.1002/gcc.22669. Epub 2018 Sep 11. Genes Chromosomes Cancer. 2018. PMID: 30203894
TERT promoter mutations in actinic keratosis before and after treatment.
Srinivas N, Neittaanmäki N, Heidenreich B, Rachakonda S, Karppinen TT, Grönroos M, Tani TT, Salmivuori M, Snellman E, Hemminki K, Kumar R. Srinivas N, et al. Among authors: kumar r. Int J Cancer. 2020 May 15;146(10):2932-2934. doi: 10.1002/ijc.32878. Epub 2020 Jan 30. Int J Cancer. 2020. PMID: 31970758 Free article. No abstract available.
TERT promoter mutations in melanoma survival.
Nagore E, Heidenreich B, Rachakonda S, Garcia-Casado Z, Requena C, Soriano V, Frank C, Traves V, Quecedo E, Sanjuan-Gimenez J, Hemminki K, Landi MT, Kumar R. Nagore E, et al. Among authors: kumar r. Int J Cancer. 2016 Jul 1;139(1):75-84. doi: 10.1002/ijc.30042. Epub 2016 Mar 2. Int J Cancer. 2016. PMID: 26875008 Free PMC article.
Pancreatic cancer susceptibility loci and their role in survival.
Rizzato C, Campa D, Giese N, Werner J, Rachakonda PS, Kumar R, Schanné M, Greenhalf W, Costello E, Khaw KT, Key TJ, Siddiq A, Lorenzo-Bermejo J, Burwinkel B, Neoptolemos JP, Büchler MW, Hoheisel JD, Bauer A, Canzian F. Rizzato C, et al. Among authors: kumar r. PLoS One. 2011;6(11):e27921. doi: 10.1371/journal.pone.0027921. Epub 2011 Nov 18. PLoS One. 2011. PMID: 22125638 Free PMC article.
TERT promoter mutations in clear cell renal cell carcinoma.
Hosen I, Rachakonda PS, Heidenreich B, Sitaram RT, Ljungberg B, Roos G, Hemminki K, Kumar R. Hosen I, et al. Among authors: kumar r. Int J Cancer. 2015 May 15;136(10):2448-52. doi: 10.1002/ijc.29279. Epub 2014 Oct 30. Int J Cancer. 2015. PMID: 25331263 Free article.
Telomere length in circulating lymphocytes: Association with chromosomal aberrations.
Hemminki K, Rachakonda S, Musak L, Vymetalkova V, Halasova E, Försti A, Vodickova L, Buchancova J, Vodicka P, Kumar R. Hemminki K, et al. Among authors: kumar r. Genes Chromosomes Cancer. 2015 Mar;54(3):194-6. doi: 10.1002/gcc.22225. Epub 2014 Nov 27. Genes Chromosomes Cancer. 2015. PMID: 25428887 No abstract available.
18,485 results
You have reached the last available page of results. Please see the User Guide for more information.